Cite

HARVARD Citation

    Glintborg, D. et al. (2018). Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS. Endocrine connections. 7 (3), pp. 479-489. [Online]. 
  
Back to record